1. Market Research
  2. > Pathology
20 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Plasma Therapy Market (Pure PRP, Leukocyte-Rich PRP, Pure PRF, Leukocyte-Rich PRF): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

  • $ 1250
  • May 2020
  • 120 pages

Also, growing cases of general blood cancers like leukemia, myeloma and lymphoma are increasingly being observed in the US.

  • Lymphoma
  • Therapy
  • World
  • Market Size
  • Biotest AG

Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

  • $ 1800
  • April 2020
  • 128 pages

People being treated with intensive therapy for leukemia or lymphoma, and other forms of cancer, are among those more prone to catching pneumonias, including the viral versions.

  • Cancer
  • Lymphoma
  • Specialty Hospital
  • Therapy
  • World

Global Orphan Drugs Market: Industry Analysis & Outlook (2018-2022)

  • $ 1000
  • July 2018
  • 79 pages

Celgene also gains full global rights to JCAR## (lisocabtagene maraleucel; liso-cel), a CD-## targeted CAR-T therapy currently in pivotal trials for relapsed and/ or refractory diffuse large B-cell lymphoma (DLBCL).

  • Lymphoma
  • Therapy
  • World
  • Bristol-Myers Squibb Company
  • Celgene Corporation

Global Proton Therapy Market: Industry Analysis & Outlook (2017-2021)

  • $ 800
  • November 2017
  • 86 pages

Lymphomas Early stage prostate carcinoma Locally advanced prostate carcinoma Pelvic Sarcoma Pediatric malignancies Ewing' s sarcoma Central Nervous System ##.

  • Hospital
  • World
  • Hitachi, Ltd.
  • Ion Beam Applications S.A.
  • Varian Medical Systems, Inc.

Global Monoclonal Antibodies Market (By Source, Application, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

  • $ 1800
  • July 2020
  • 128 pages

CD##β Humanized IgG## ADC Hybridoma Diffuse large Bcell lymphoma Brolucizumab Beovu Novartis Pharmaceuticals Corp.

  • Lymphoma
  • Monoclonal Antibody
  • Targeted Therapy
  • World
  • Market Size

Global Thrombocytopenia (Immune & Chemotherapy-induced) Market: Insights, Trends and Forecast (2019-2023)

  • $ 1600
  • September 2019
  • 95 pages

Lymphoma Aplastic anemia Heavy alcohol consumption Vitamin deficiency anemia, including vitamin B## & folate deficiency anemia Some bone marrow disorders Some chemotherapy drugs Platelets become entrapped in an enlarged spleen Cirrhosis of the liver that causes spleen enlargement due to

  • Blood Disease
  • Hospital
  • Lymphoma
  • World
  • Novartis AG

Global Chimeric Antigen Receptor (CAR) T-Cell Therapy: Industry Analysis & Outlook (2019-2023)

  • $ 1000
  • February 2019
  • 93 pages

It is FDA approved treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more line of systemic therapy including diffuse large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lumphoma, high grade B-cell lymphoma and DLBCL aris

  • Immunotherapy
  • Lymphoma
  • Therapy
  • World
  • Celgene Corporation

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2029)

  • $ 1700
  • July 2020
  • 102 pages

Hematology/ Oncology: it includes medication for hematology (diseases such as iron deficiency anemia, hemophilia, sickle cell disease, the thalassemias, leukemias and lymphomas) and oncology (cancer).

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • World
  • Gilead Sciences, Inc.

Global Antiretroviral Therapy Market (NRTI, NNRTI, Protease Inhibitors & Integrase Inhibitors): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

  • $ 1250
  • May 2020
  • 98 pages

On ## April, 2020, Abbvie announced that the US FDA has approved the use of IMBRUVICA in combination with rituximab for the treatment of previously untreated patients with chronic lymphocytic leukemia (CLL), or small lymphocytic lymphoma (SLL).

  • HIV Antiviral
  • Lymphoma
  • Therapy
  • World
  • Roche Group

Global Latent Tuberculosis Infection (LTBI) Testing Market Report: Insights, Trends & Forecast (2019-2023)

  • $ 1700
  • July 2019
  • 106 pages

lymphoma (DLBCL), have received at least two prior therapies.

  • Lymphoma
  • Tuberculosis
  • World
  • Forecast
  • Thermo Fisher Scientific, Inc.

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Insights, Trends and Forecast (2019-2028)

  • $ 1600
  • August 2019
  • 96 pages

Hematology/ Oncology: it includes medication for hematology (diseases such as iron deficiency anemia, hemophilia, sickle cell disease, the thalassemias, leukemias and lymphomas) and oncology (cancer).

  • Lymphoma
  • Therapy
  • World
  • Forecast
  • Gilead Sciences, Inc.

Global In-Vitro Diagnostics (IVD) Market Report: Insights, Trends and Forecast (2019-2023)

  • $ 1800
  • August 2019
  • 112 pages

Food and Drug Administration (FDA) has granted accelerated approval to Polivy (polatuzumab vedotin-piiq) in combination with bendamustine plus Rituxan (rituximab) (BR) for the treatment of adults with relapsed or refractory (R/ R) diffuse large B-cell lymphoma (DLBCL), who have received

  • In Vitro Diagnostics
  • Lymphoma
  • Point Of Care Testing
  • World
  • Market Size

Global Proton Therapy Market Report: Insights, Trends & Forecast (2019-2023)

  • $ 1700
  • August 2019
  • 106 pages

Lymphomas Early stage prostate carcinoma Locally advanced prostate carcinoma Pelvic Sarcoma Pediatric malignancies Ewing' s sarcoma Central Nervous System ##.

  • Cancer
  • Hospital
  • World
  • Market Size
  • Varian Medical Systems, Inc.

Global Dental Market (Restoratives, Implants, Orthodontics, Endodontic, Prosthetics & Equipment): Insights, Trends and Forecast (2019-2023)

  • $ 1800
  • July 2019
  • 134 pages

Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types: teratoma, adenocarcinoma derived from a major or minor salivary gland, lymphoma from tonsillar or other lymphoid tissue, or melanoma from the pigment-producing cells of t

  • Dental Equipment
  • Dentistry
  • Lymphoma
  • World
  • Zimmer Biomet Holdings, Inc.

Global Vaccines Market with focus on China: Industry Analysis & Outlook (2018-2022)

  • $ 1100
  • August 2018
  • 85 pages

KEYTRUDA for Treatment of Refractory or Relapsed Primary Mediastinal Large B-Cell Lymphoma (PMBCL) June ##, 2018- The company announced FDI approval of Keytruda, the company' s anti-PD-## therapy, for the treatment of adult and pediatric patients with refractory primary mediastinal large

  • Lymphoma
  • Therapy
  • Vaccine
  • World
  • Market Size

Global Dental Market (Restoratives, Implants, Orthodontics, Endodontic, Prosthetics & Equipment): Industry Analysis & Outlook (2018-2022)

  • $ 900
  • September 2018
  • 115 pages

Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types: teratoma, adenocarcinoma derived from a major or minor salivary gland, lymphoma from tonsillar or other lymphoid tissue, or melanoma from the pigment-producing cells of t

  • Dental Equipment
  • Dentistry
  • Lymphoma
  • World
  • Straumann Holding AG

Global Multiple Myeloma Market: Industry Analysis & Outlook (2016-2030)

  • $ 800
  • August 2016
  • 53 pages

The two main types of lymphoma are: ##.

  • Lymphoma
  • Therapy
  • World
  • Forecast
  • Sanofi S.A.

Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020

  • $ 800
  • July 2016
  • 45 pages

Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, ...

  • Autoimmune Disease
  • Pathology
  • Therapy
  • United States
  • Novartis AG

Global Gastric Cancer Market Report: 2016 Edition

  • $ 800
  • May 2016
  • 52 pages

On ## February 2016, FDA approved Roche' s Gazyva for certain people with previously treated follicular lymphoma.

  • Cancer
  • Gastric Cancer
  • Lymphoma
  • Pathology
  • Merck & Co., Inc.

Adrenal Insufficiency Market Report: 2016 Edition

  • $ 800
  • June 2016
  • 45 pages

Adrenal Insufficiency is a rare disease in which the adrenal glands are unable to produce sufficient amount of the hormones cortisone, aldosterone or Dehydroepiandrosterone, which are essential for vital ...

  • Hormone
  • Lymphoma
  • United States
  • World
  • Strongbridge Biopharma plc


View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on